TY - JOUR T1 - Common genetic variant of GC associated with vitamin D deficiency in a Chinese population in the Netherlands JF - medRxiv DO - 10.1101/2022.08.08.22278561 SP - 2022.08.08.22278561 AU - Ping Wai Man AU - Stefan Böhringer AU - Elisa J.F. Houwink AU - Wenzhi Lin AU - Mattijs E. Numans AU - Paul Lips AU - Barend J. C. Middelkoop Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/08/10/2022.08.08.22278561.abstract N2 - Background Genome-wide association studies among European populations have identified four single nucleotide polymorphisms (SNPs) in genes involved in vitamin D transport and metabolism affecting 25-hydroxyvitamin D [25(OH)D] concentration: rs2282679 in GC, rs6013897 near CYP24A1, rs10741657 near CYP2R1, and rs12785878 near DHCR7. It is, however, unknown whether the association with 25(OH)D can also be observed in a Chinese population living in the Netherlands.Methods Observational study. Analyses were performed under an additive (univariate and multivariate) and genotypic model using logistic regression.Results The C allele (minor allele frequency 0.28) of rs2282679 in GC was associated with vitamin D deficiency as defined by the Health Council of the Netherlands: 25(OH)D <30 nmol/l (or <50 nmol/l for persons aged ≥70 years). Univariate and multivariate odds ratios, 1.52 (95% CI 1.03, 2.24) and 1.57 (95% CI 1.04, 2.39), respectively, were not significant after Bonferroni correction. However, after extending the data by a meta-analysis, a significant association between C allele of rs2282679 and vitamin D deficiency (< 50 nmol/l) was observed (odds ratio 1.33; 95% CI 1.16, 1.52).Conclusion Our findings suggest that, apart from sun exposure, lifestyle, and environmental factors, a common variant of GC may be associated with vitamin D deficiency.Competing Interest StatementPaul Lips has received a lecture fee from Abiogen. The other authors declare that they have no conflict of interest. Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving research study participants were approved by the Medical Ethical Committee of the Leiden University Medical Center (approval number P13.279). Written informed consent was obtained from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request. ER -